Amylyx Pharmaceuticals Announces Positive Long-Term Results from Phase 2 HELIOS Clinical Trial of AMX0035 in People with Wolfram Syndrome
Stocks in this Quantisnow insightHealth Care
Quantisnow market dataNASDAQ
AMLX
Amylyx Pharmaceuticals Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2022
Get push alerts for AMLX
Full AMLX profile on Quantisnow Follow AMLX and get a push notification the moment its next story breaks.